Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/07/1996 | WO1996004393A3 Control of plant gene expression |
03/07/1996 | WO1996004385A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
03/07/1996 | WO1996003515A3 Surface expression of enzyme in gene directed prodrug therapy |
03/07/1996 | WO1996003509A3 Insect viruses, sequences, insecticidal compositions and methods of use |
03/07/1996 | WO1996003506A3 Analog of haemophilus hin47 with reduced protease activity |
03/07/1996 | WO1996002641A3 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma |
03/07/1996 | WO1995032291A3 Hepatitis g virus and molecular cloning thereof |
03/07/1996 | DE19532001A1 New antibacterial peptide, moricin, from silkworms |
03/07/1996 | DE19531931A1 Modulatoren des Körpergewichts, korrespondierende Nukleinsäuren und Proteine, und diagnostische und therapeutische Verwendungen derselben Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
03/07/1996 | CA2198919A1 Gradual modification, super agonists and antagonists of signs and peptides |
03/07/1996 | CA2198891A1 Genetically modified t cells |
03/07/1996 | CA2198780A1 Diagnostic test using fc receptor |
03/07/1996 | CA2198757A1 Device for use in the isolation of a biological material such as nucleic acid |
03/07/1996 | CA2198587A1 Trophic factors for central nervous system regeneration |
03/07/1996 | CA2198489A1 Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to a solid surface |
03/07/1996 | CA2198474A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
03/07/1996 | CA2198473A1 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound |
03/07/1996 | CA2198472A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
03/07/1996 | CA2198462A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle |
03/07/1996 | CA2198451A1 Transgenic animal expressing a familial form of human amyloid precursor protein |
03/07/1996 | CA2198345A1 Improvements in production of proteins in host cells |
03/07/1996 | CA2198080A1 Cell cycle regulated repressor and dna element |
03/07/1996 | CA2197901A1 Reduction of nonspecific hybridization by using novel base-pairing schemes |
03/07/1996 | CA2197777A1 Novel ribozymes and novel ribozyme selection systems |
03/07/1996 | CA2197774A1 A method of selecting pluripotent hematopoietic progenitor cells |
03/07/1996 | CA2197452A1 Methods and test kits for specific and sensitive diagnosing of periodontal diseases |
03/07/1996 | CA2197427A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
03/07/1996 | CA2183649A1 Method for increasing plasmid yield |
03/07/1996 | CA2174844A1 Arabinoxylan degrading enzymes |
03/06/1996 | EP0699768A1 Methods for in-solution quenching of fluorescently labeled oligonucleotide probes |
03/06/1996 | EP0699766A1 Therapeutic antibody based fusion proteins with platelet factor-4 |
03/06/1996 | EP0699765A1 DNA, constructs, cells and plants derived therefrom |
03/06/1996 | EP0699764A1 A method of using eukaryotic expression vectors comprising the BK virus enhancer |
03/06/1996 | EP0699763A1 Nucleic acid sequence encoding trypsin-like enzyme and process for producing the enzyme |
03/06/1996 | EP0699762A2 Novel Phytase |
03/06/1996 | EP0699761A2 Heptaprenyl diphosphate synthesizing enzyme and dna encoding same |
03/06/1996 | EP0699760A1 Purified DNA polymerase from bacillus stearothermophilus |
03/06/1996 | EP0699759A1 Variant aspartokinase gene |
03/06/1996 | EP0699758A1 Prototype felv isolates for use in disease models and vaccines |
03/06/1996 | EP0699757A1 Potyvirus coat protein genes and plants transformed therewith |
03/06/1996 | EP0699756A1 Novel mutant BR96 antibodies and functional equivalents reactive with human carcinomas |
03/06/1996 | EP0699755A2 Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing them |
03/06/1996 | EP0699754A1 Method for diagnosing a predisposition for breast and ovarian cancer |
03/06/1996 | EP0699753A2 Protein for the transport of cationic xenobiotic and/or pharmaceutical compounds, DNA sequences coding therefore and its uses |
03/06/1996 | EP0699752A2 Mutated recombinant collagens |
03/06/1996 | EP0699751A1 Antisense complementary to HCV genome |
03/06/1996 | EP0699750A1 A collection of phagemids, a collection of Escherichia coli cells carrying the phagemids, a collection of phagemid particles produced from said collection and phagemid particles obtained according to the process |
03/06/1996 | EP0699749A1 Recombinant cycloisomaltooligosaccharide synthase, DNA encoding it, and its use |
03/06/1996 | EP0699748A2 Decreased hydrogen sulfide formation in beer production |
03/06/1996 | EP0699248A1 Methods for treating non-cotton-containing fabrics with cellulase |
03/06/1996 | EP0699240A1 Gibbon ape leukemia virus-based retroviral vectors |
03/06/1996 | EP0699239A1 Genetic stabilizing elements |
03/06/1996 | EP0699238A1 Dna encoding two fish neuropeptides |
03/06/1996 | EP0699237A1 Anti-egfr single-chain fvs and anti-egfr antibodies |
03/06/1996 | EP0699236A1 Purified mammalian flt3 ligands and agonists and antagonists thereof |
03/06/1996 | EP0699208A1 Novel peptide nucleic acids |
03/06/1996 | EP0699079A1 Bioactive and/or targeted dendrimer conjugates |
03/06/1996 | EP0699077A1 Hiv immunogenic complexes |
03/06/1996 | EP0699076A1 Otitis media vaccine |
03/06/1996 | EP0699071A1 Anti-viral guanosine-rich oligonucleotides |
03/06/1996 | EP0699023A1 Enhanced insect resistance in plants genetically engineered with a plant hormone gene involved in cytokinin biosynthesis |
03/06/1996 | EP0677194A4 Oligoprobe designstations: a computerized method for designing optimal oligonucleotide probes and primers. |
03/06/1996 | EP0652769B1 Vaccines against metazoan parasites |
03/06/1996 | EP0620853B1 Materials and methods for biosynthesis of serine and serine-related products |
03/06/1996 | EP0479899B1 Vasodilatory and immune suppressant peptides |
03/06/1996 | EP0476059B1 Methods for enhancing the rate of modification of metastable bonds |
03/06/1996 | EP0395653B1 Synovial phospholipases |
03/06/1996 | EP0387319B1 Secretory leader sequences |
03/06/1996 | EP0362259B1 Method of producing cystatin c or modifications hereof and dna-sequence for use when carrying out the method |
03/06/1996 | EP0315637B1 Polypeptides useful in diagnosis of mycoplasma infections in swine and recombinant-dna methods for manufacturing same |
03/06/1996 | CN1118172A Oxidatively stable alpha-amylase |
03/06/1996 | CN1118168A Structured copolymers used as absorbents, gels and carriers of metal ions |
03/06/1996 | CN1118131A An enzyme feed additive and animal feed including it |
03/06/1996 | CN1118008A Erythropoietin for human |
03/06/1996 | CN1117873A Usage of follicle-stimulating hormone |
03/06/1996 | CA2157531A1 Htfiiia gene |
03/05/1996 | US5496938 Nucleic acid ligands to HIV-RT and HIV-1 rev |
03/05/1996 | US5496934 Nucleic acids encoding a cellulose binding domain |
03/05/1996 | US5496926 Process of preparing a soluble LDL receptor |
03/05/1996 | US5496732 Dna sequence encoding isopentenyl transferase |
03/05/1996 | US5496731 Anti-oncogenes |
03/05/1996 | US5496724 Genes encoding platelet aggregation inhibitors |
03/05/1996 | US5496721 Methods of generating desired amino-terminal residues in proteins |
03/05/1996 | US5496720 Increasing intracellular calcium levels; phosphorylation prevention |
03/05/1996 | US5496714 Modification of protein by use of a controllable interveining protein sequence |
03/05/1996 | US5496713 Process for producing 20 kD human growth hormone |
03/05/1996 | US5496711 Genetic engineering with dna using fungi, yeasts and bacteria |
03/05/1996 | US5496699 Dna deproteinizing with enzymes, denaturing strands, amplification of mutant allele and primers |
03/05/1996 | US5496698 Method of isolating ribozyme targets |
03/05/1996 | US5496562 Solid medium and method for DNA storage |
03/05/1996 | CA1338122C Tissue factor inhibitor of coagulation |
03/04/1996 | EP0711347A4 Ph genes and their uses |
02/29/1996 | WO1996006191A2 Primers and probes for the amplification and detection of cmv nucleic acid |
02/29/1996 | WO1996006190A2 Coupled amplification and ligation method |
02/29/1996 | WO1996006188A1 Peptide librairies as a source of syngenes |
02/29/1996 | WO1996006177A2 Retrovirus-like particles made non-infectious by a plurality of mutations |
02/29/1996 | WO1996006176A1 Functional modified hsv1-tk |
02/29/1996 | WO1996006175A2 Fumonisin-detoxifying enzymes |
02/29/1996 | WO1996006174A1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES |
02/29/1996 | WO1996006173A1 Genetic manipulation of plants to increase stored carbohydrates |